Title: Brown SP, et al. Discovery of AM-1638: A Potent and Orally Bioavailable GPR40/FFA1 Full Agonist. ACS Med Chem Lett. 2012 Aug 15;3(9):726-30.
50915-27-0 | 1-Bromo-1-methylcyclopropane | AA00IKMB | MFCD28539063
1146289-83-9 | 1-(heptafluoropropoxy)-4-nitrobenzene | AA019M9F | MFCD11857765
102793-81-7 | 1-(2-bromoethoxy)-4-(trifluoromethoxy)benzene | AA019T1E | MFCD20731206
1016531-70-6 | 6-chloro-N-(pentan-2-yl)pyridine-3-sulfonamide | AA019VHW | MFCD09802874
1223468-06-1 | 2,2,2-trifluoroethyl N-[1-(1H-imidazol-1-yl)propan-2-yl]carbamate | AA019XW2 | MFCD16039986
1016510-22-7 | 2-(([(3-Nitrophenyl)methyl]carbamoyl)amino)acetic acid | AA01A8HG | MFCD09805900
1249675-43-1 | 4-(3-iodophenoxy)pyridine | AA01AA79 | MFCD14659279
110817-67-9 | 1-[(4-methoxyphenyl)amino]cyclopentane-1-carboxamide | AA01AGWR | MFCD12897759
1355773-02-2 | ethyl 3-imino-2-(piperidin-4-yl)-2,3-dihydro-1H-pyrazole-4-carboxylate dihydrochloride | AA01AIKB | MFCD28155356
1199783-17-9 | 4,6-dichloro-2,3-dihydro-1H-inden-1-amine hydrochloride | AA01BD7Z | MFCD08544169
